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Gonorrhea and syphilis co-infection and related risk 
factors in HIV patients from Shiraz, South of Iran 
 
 
Abstract 
Background: Neisseria gonorrhea and Treponema pallidum as an obligate human 
pathogen are two common causes of sexually transmitted diseases (STDs). The present 
study aimed to determine the prevalence of N. gonorrhoeae and T. pallidum among human 
immunodeficiency virus (HIV) patients in the southwest Iran. 
Methods: This retrospective study was performed from 2004 to 2013, on HIV patients 
who were tested for detection of gonorrhea and syphilis infection at Shiraz HIV/AIDS 
Research Center. ELISA technique was used for preliminary detection of HIV and 
confirmed by a Western Blotting test. Gonorrhea was routinely diagnosed using direct 
Gram-staining and culturing on selective agar. Syphilis was routinely diagnosed by RPR test. 
Results: Of the 806 HIV patients, 39 (2.6%) cases had co-infection with gonorrhea. 
Compared with mono-HIV infected patients, gonorrhea was significantly more likely 
among the males (69.4% vs. 92.3%, P=0.002). History of addiction and prison seems to be 
a significant risk factor for gonorrhea infection (P<0.05). Also, the mean of 
CD4+lymphocyte was higher among gonorrhea infected patients (368±238 vs. 415±328). 
Logistic regression analysis showed that sexual contact increased risk of gonococcal 
infection about 4 fold (OR: 4, CI: 1.7-9.39, P=0.001). None of the HIV patients had 
syphilis co-infection. 
Conclusions: As a preliminary survey, our findings provided unique information on the 
prevalence of gonorrhea and syphilis co-infections among HIV patients. Moreover, we 
introduced the main risk factors associated with gonorrhea co-infection in HIV patients in 
our region including gender, history of addiction and prison, CD4+lymphocyte count, and 
transmission routes for effective management of STDs. 
Keywords: Sexually transmitted disease, Human immunodeficiency virus, Neisseria 
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Sexually transmitted diseases (STDs) are one the major public health concern in the 
world (1). Neisseria gonorrhea is an obligate human pathogen responsible for gonorrhea 
as one of the commonest sexually STDs (2). The World Health Organization (WHO) 
estimates a significant increase in the global incidence of N. gonorrhoeae from 87.7 to 
106.1 million new cases between years 2005 to 2008 (3). While there are no 
comprehensive data on incidence of N. gonorrhoeae from Iran, WHO reports in 2008 
indicated 3.1 million new cases of N. gonorrhoeae from Eastern-Mediterranean region 
including Iran (3). Although gonorrhea infections can usually appear asymptomatic, if 
infection left untreated, it can cause severe complications such as urethritis and cervicitis 
(2). Syphilis is one of the most important STDs, caused by the bacterium Treponema pallidum (4). 
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The same transmission route and risk factors are possible 
occurrence of HIV and T. pallidum co-infection (5). Despite 
decades of clinical experience with co-infected patients, the 
interaction between HIV and syphilis remains complicated 
and the clinical treatment of co-infected patients remains 
challenging. (6). There is strong evidence that STDs, 
especially gonorrhea and syphilis, impact the dynamics of 
human immunodeficiency virus (HIV) infection (7). These 
infections facilitate the acquisition of HIV infection via 
damage to the genital tract or skin (7). Furthermore, 
gonorrhea and syphilis potentially increase the risk of viral 
shedding and subsequently transmission of HIV (6, 8). 
Recent estimates have suggested that nearly a hundred 
thousand patients with HIV are living in Iran (9); however, 
there is no record on the prevalence of N. gonorrhoeae co-
infection among HIV patients in Iran. The emergence of 
resistant strains of N. gonorrhoeae to wide range of 
antimicrobial agents is a global challenge to deal with 
gonorrhea infections (10). Early diagnosis has an important 
role in reducing unwanted outcomes of gonorrhea and 
syphilis infections. Therefore, the aim of present study was 
to determine the frequency of gonorrhea and syphilis co-
infection among HIV patients and the potential impact of 
other risk factors on this situation in the south-west of Iran. 
 
 
Methods 
Study setting and design: This retrospective study was 
performed within a ten year period from 2004 to 2013 
among HIV positive patients at Shiraz HIV/AIDS Research 
Center. Shiraz HIV/AIDS Research Center as the second 
HIV/AIDS Research Center in Iran is affiliated to Shiraz 
University of Medical Sciences, located in Shiraz, the south-
west of Iran.  Shiraz HIV/AIDS Research Center specializes 
in counseling, treatment and research related to HIV/AIDS.  
Totally, 806 HIV patients with complete medical records 
were enrolled in presents study. Cases without or missing 
medical records were excluded. This study was approved by 
the Ethics Committee of Shiraz University of Medical 
Sciences (Local register code: IR.SUMS.MED.REC. 1395. 
s11) and was in accordance with the declaration of Helsinki. 
The ethics committee waived the need for informed consent 
because we only used medical records and ensured about the 
patient confidentiality with no personal data.  
Diagnosis of HIV and co-infections: Enzyme linked 
immunosorbent assay (ELISA) (Dia.Pro Diagnostic 
Bioprobes, Italy) technique was used for preliminary 
detection of HIV infection. Subsequently, primary positive 
results were then confirmed by a Western Blotting test. 
Syphilis was routinely diagnosed by the consistency of the 
clinical manifestations and the rapid plasma reagin (RPR) 
(Bionik, Tehran, Iran) test was used to serological detection. 
Gonorrhea was routinely diagnosed by standard 
microbiological procedures. The specimen was collected 
based on main criteria for males and females and was 
identified by using direct gram staining and culturing on 
selective agar (11). Demographic and clinical data, such as 
age, gender, prison history, addiction history, transmission 
route and CD4+ lymphocyte count were also evaluated for 
all participants.  
Statistical analysis: Analysis was performed using SPSS
TM
 
software, Version 21.0 (IBM Corp., USA). The results are 
presented as descriptive statistics in terms of relative 
frequency. Values were expressed as the mean ± standard 
deviation (continuous variables) or percentages of the group 
(categorical variables). Chi–square or Fisher's exact tests was 
used to estimate any statistical association for quantitative 
variables, and paired t-tests were used to compare means. A 
p<0.05 was regarded as significant relevance. Logistic 
regression modeling was performed to identify the factors 
associated with risk of gonococcal infection among HIV 
patients. The associations which were presented as odds ratio 
(OR) together with 95% confidence interval (CI) were 
considered as significant if the corresponding 95% CI does 
not include one. 
 
 
Results 
Of the total 806 HIV patients who were tested for 
gonococcal infection, 39 (2.6%) cases had gonorrhea. 
Despite the higher occurrence of gonorrhea infection among 
older patients, compared to mono-infected ones, no 
significant differences were found. Compared with mono-
HIV infected patients, gonorrhea infection was more likely 
among males (92.3 vs. 69.4%, P<0.05). Addiction and prison 
history seems to be a risk factor for gonorrhea infection, 
since the majority of gonorrhea infected patients, compared 
to non-infected patients, experienced drug addiction and 
prison (89.7 vs. 68.4% and 84.6 vs. 60.6%, respectively, 
P<0.05). Also, the majority of gonorrhea infected patients 
experienced sexual contact in their life; compared to HIV 
mono-infected patients, the proportions were significantly 
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higher (79.5 vs. 42.2%, P<0.001). The common HIV 
infection transmission routes in both gonorrhea infected and 
non-infected patients was intravenous drug use (IDU) and 
sexual contact, but patients infected via IDU had a 
significant risk for co-infection with gonorrhea (P<0.05).  
Among the clinical risk factors evaluated, there was no 
significant association between highly active antiretroviral 
therapy (HAART) and gonorrhea infection. Also, although 
compared with HIV mono-infected, the mean of 
CD4+lymphocyte was higher among gonorrhea infected 
patients (368±238 vs. 415±328, respectively), but the 
difference was not significant. The full results of 
demographic and clinical characteristics of HIV and 
gonorrhea infection among the studied cases was shown in 
Table 1. Logistic regression analysis showed that sexual 
contact significantly increased the chances of gonococcal 
infection about 4 fold (OR: 4, CI: 1.7-9.39, P=0.001). The 
full results of logistic regression modeling for risk factors 
associated with gonococcal co-infection are shown in table 2. 
Based on the laboratory results, of the totally tested HIV 
patients for syphilis infection, no positive case was found by 
RPR test. 
 
Table 1: Demographic and clinical characteristics of HIV and gonorrhea infection among the studied cases 
Groups 
 
Studied factors 
HIV mono-infected 
n (%) 
(Total=767) 
Gonorrhea co-infected 
n (%) 
(Total=39) 
p-value 
Age (years)    
Mean ± SD 38±9 40±8 0.17 
range 2-70 24-61  
<19 years old 20 (2.6) 0  
20-50 677 (88.3) 35 (89.7) 0.36 
>51 70 (9.1) 4 (10.3)  
Gender    
Male 532 (69.4) 36 (92.3) 0.002 
Female 235 (30.6) 3 (7.7)  
HAART therapy    
Yes 517 (67.4) 25 (64.1) 0.66 
No 250 (32.6) 14 (35.9)  
Addict history    
Yes 525 (68.4) 35 (89.7) 0.005 
No 242 (31.6) 4 (10.3)  
Prison history    
Yes 465 (60.6) 33 (84.6) 0.003 
No 302 (39.4) 6 (15.4)  
Blood transfusion history  
 
 
Yes 49 (6.4) 2 (5.1) 0.75 
No 718 (93.6) 37 (94.9)  
Sexual contact 
  
 
Yes 324 (42.2) 31 (79.5) 0.001 
No 443 (57.8) 8 (20.5)  
Transmission route    
 
 
0.006 
Intravenous drug use 448 (58.4) 33 (84.6) 
Sexual contact 250 (32.6) 4 (10.3) 
Mother to Infant 18 (2.4) 0 
Blood transfusion 3 (0.4) 1 (2.5) 
Occupational   exposure 1 (0.1) 0 
Unknown 47 (6.1) 1 (2.5) 
CD4+lymphocyte    
Mean ± SD 368±238 415±328 0.23 
Range 10-1678 21-1691  
<200/μl Cells/mm3 182 (23.7) 7 (17.9) 0.56 
≥200/μl Cells/mm3 585 (76.3) 32 (82.1)  
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Table 2. Logistic regression modeling for factors associated with risk of gonococcal infection among HIV patients. 
 
Factor Subgroup OR (95% CI) Significant level 
Age Age 1.03 (0.99-1.07) 0.13 
Gender 
Female Ref 
0.31 
Male 2.51 (0.42-15.07) 
HAART therapy 
No Ref 
0.99 
Yes 1 (0.49-2.03) 
Addict history 
No Ref 
0.30 
Yes 0.3 (0.03-2.96) 
Prison history 
No Ref 
0.48 
Yes 1.69 (0.4-7.15) 
Blood transfusion history 
No Ref 
0.48 
Yes 0.59 (0.14-2.58) 
Sexual contact 
No Ref 
0.001 
Yes 4 (1.7-9.39) 
Transmission route 
Other Ref 
0.25 
Intravenous drug use 2.37 (0.54-10.42) 
CD4+lymphocyte 
<200/μl Cells/mm3 Ref 
0.27 
≥200/μl Cells/mm3 1.63 (0.69-3.85) 
 
Discussion  
STDs include a range of infections that, regardless of 
gender, usually lead to a clinical complication (2). 
Gonorrhea, as an important cause of STDs, can lead to a 
syndemic relationship with HIV/AIDS (12). Physical and 
molecular role of gonorrhea infection in facilitating HIV 
acquisition and transmission is undeniable; besides the risk 
of resistance, gonorrhea could become a serious concern of 
public health (7, 10). Control and prevention of this co-
infection need an adequate surveillance in every part of the 
world (7, 13). Given this fact, our results revealed the 
prevalence of gonorrhea infection 2.6% among HIV patients 
in Shiraz, southwest of Iran. To the best of our knowledge, 
this is the first report from Iran and there is no previous 
record on the prevalence of HIV/gonorrhea co-infection to 
compare of our situation with others in neighborhood 
regions. Nonetheless, compared to previous reports on the 
prevalence of gonorrhea infection among non- HIV infected 
individuals from different parts of our country, gonorrhea 
infection among HIV patients seems to have a relatively 
higher rate; yet, most of these studies are conducted among 
women (2, 14-16). Similar reports from other parts of the 
world indicated the variability of gonorrhea infection among 
HIV patients (8, 17-19), which could originate from 
diagnostic or lifestyle differences in these regions (14).  
 
However, the prevalence reported in our study (2.6%) is 
lower than those reported among HIV positive patients in 
Kenya (17%) (20), capital of India (9%) (21), and Arizona 
state of the USA (4.5%) (12), whereas it is higher than those 
reported from California state of USA (2%), India (2%) , and 
Brazil (0%) (18). Furthermore, besides the higher incidence 
of gonorrhea infection in men, among the other socio-
demographic factors that were studied, history of drug 
addiction, prison and sexual contact is a significant risk 
factor for occurrence of gonorrhea co-infection. The 
relationship of these risk factors has also been reported in 
other studies (22). Although occasion of gonorrhea 
acquisition in our studied patients are unavailable (inside or 
outside the prison), one of the reasons for higher chance of 
gonorrhea infection among male prisoners attributed to more 
tendency for risky behaviors, such as unprotected intercourse 
and also lower knowledge about STDs (23, 24). Rectal 
gonorrhea and anal warts were mentioned as important risk 
factors for HIV acquisition (25). 
In our study, assessment of CD4+ lymphocyte count 
revealed a higher mean of CD4+ lymphocyte among gonor-
rhea infected than non-infected patients, although the 
difference was not statistically significant, Levine et al. 
previously showed that the median of endocervical CD4+ 
lymphocyte was significantly greater among patients with 
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STDs than among those without them and it may facilitate 
HIV transmission by increasing the presence of CD4+ 
lymphocytes at endocervix (26). Hopefully, in our results 
none of the HIV patients had syphilis co-infection. The only 
data on prevalence of T. pallidum among Iranian HIV-
positive patients by Badie et al. showed 0.45% co-infection 
(5). Other attempts on the determination of syphilis 
prevalence among Iranian high risk groups showed low rates 
of detection closest to our findings (27-29).Self-medication 
or antibiotic therapy for treating irrelevant diseases may be 
one of the main causes of such observations.  
Finally, our study had some limitations. Although the 
traditional approaches, such as the use of selective culture, is 
still the preferred laboratory test for diagnosis of gonorrhea, 
for some conditions and specimens, the nucleic acid 
amplification tests (NAATs) have a higher sensitivity 
compared to traditional methods (1). Moreover, it would be 
better to have access to time of gonorrhea detection (before 
or after HIV infection) for determining the probable effect of 
using HAART on the prevalence of HIV/gonorrhea co-
infection.  
In conclusion, despite the limitations, our study, as a 
preliminary survey, provided unique information on the 
prevalence of gonorrhea and syphilis co-infections among 
HIV infected patients for clarification of our situation and 
also comparison with others. Additionally, we introduced the 
main risk factors associated with gonorrhea co-infection in 
HIV patients in our region which could provide a good 
background for effective management of prevalence and 
prevention of these diseases. 
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